Quantum Genomics Quantum Genomics
  • Company
    • Management
    • Board of directors
    • Inventors
    • Scientific and clinical advisory board
  • Investors
    • Press releases
    • Financial documents
      • Annual information
      • Semi-annual information
      • Other regulated informations
    • Shareholder letter
    • General meetings
    • Shareholding
    • Financial calendar
    • Contacts
  • Contact us
  • Français

News

2017/06/07 – Quantum Genomics to host two upcoming events

Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing…

7 June 2017
Quantum 2017-06-07T19:30:59+02:00
News

2017/05/23 – Quantum Genomics to Host Key Opinion Leader Event Focused on Phase IIa Hypertension Data and the Upcoming Clinical Trial in the United States

Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…

23 May 2017
Quantum 2017-05-23T18:00:32+02:00
News

2017/05/09 – Quantum Genomics will organize a teleconference on June 19, 2017, to comment on phase IIa data in high blood pressure

Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…

9 May 2017
Quantum 2017-05-09T18:00:34+02:00
News

2017/04/25 – Quantum Genomics appoints Bruno Besse as Chief Medical Officer

Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…

25 April 2017
Quantum 2017-04-25T18:00:00+02:00
News

2017/03/30 – 2016 annual financial results and next development steps in 2017

Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…

30 March 2017
Quantum 2017-03-30T18:00:59+02:00
News

2017/03/14 – Quantum Genomics announces positive data from new preclinical studies with QGC001

Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…

14 March 2017
Quantum 2017-03-14T18:00:00+01:00
News

2017/02/20 – 2017 financial calendar – Quantum Genomics has joined the Pass French Tech program

Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…

20 February 2017
Quantum 2017-02-20T18:00:04+01:00
News

2017/02/02 – Quantum Genomics granted key European patent for QGC011 combination therapy program

Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…

2 February 2017
Quantum 2017-02-02T18:00:33+01:00
Information
  • Blog
  • Home
  • Contact us
About

Quantum Genomics is a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, especially high blood pressure and heart failure.

Contact us

33 rue Marbeuf
75008 Paris

[email protected]
+33(0)1 85 34 77 70

Write us

Quick access
  • Scientific Publications
Search

 

© 2019 Quantum Genomics - Legal notice - Website terms and conditions

  • Company
    • Management
    • Board of directors
    • Inventors
    • Scientific and clinical advisory board
  • Investors
    • Press releases
    • Financial documents
      • Annual information
      • Semi-annual information
      • Other regulated informations
    • Shareholder letter
    • General meetings
    • Shareholding
    • Financial calendar
    • Contacts
  • Contact us
  • Français
  • Blog
  • Home
  • Contact us